HLA expression and tumor-infiltrating immune cells in uveal melanoma

被引:72
作者
deWaardSiebinga, I
Hilders, CGJM
Hansen, BE
vanDelft, JL
Jager, MJ
机构
[1] UNIV LEIDEN HOSP, DEPT PATHOL, 2300 RC LEIDEN, NETHERLANDS
[2] UNIV LEIDEN HOSP, DEPT MED STAT, 2300 RC LEIDEN, NETHERLANDS
关键词
D O I
10.1007/BF00186516
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: In uveal melano ma, both the amount of tumor-infiltrating cells and the level of expression of HLA antigens are quite variable. We hypothesized that low levels of HLA expression lead to a lack of antigen presentation, which might prevent proper immunologic recognition of the tumor. This lack of recognition might subsequently lead to low levels of tumor-infiltrating cells. Methods: To test this hypothesis, we determined the type and number of tumor-infiltrating cells in tumor sections from 24 uveal melanomas. We applied monoclonal antibodies directed against different types of immune cells and compared the results with the expression of HLA class I and class II antigens on the turner cells. Results: Infiltrating immune cells were observed in all uveal melanomas (although in small amounts), with a predominance of T lymphocytes. Significant positive correlation:, were observed between the number of CD3+ cells (T lymphocytes) and monomorphic HLA class I expression, allele-specific HLA-A2 and Bw4 expression, and HLA class II expression. Furthermore, the number of CD4+ cells (T helper cells, monocytes/macrophages) and of CD11b+ cells (monocytes/macrophages) was significantly correlated with the level of monomorphic HLA class I expression. Conclusion: These data support our hypothesis that low levels of HLA expression (and therefore a lack of presentation of tumor-specific antigens) may lead to a low level of tumor infiltrate.
引用
收藏
页码:34 / 42
页数:9
相关论文
共 43 条
[1]   PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS [J].
BARNSTABLE, CJ ;
BODMER, WF ;
BROWN, G ;
GALFRE, G ;
MILSTEIN, C ;
WILLIAMS, AF ;
ZIEGLER, A .
CELL, 1978, 14 (01) :9-20
[2]   MONOCLONAL-ANTIBODY TO HLA-A3 [J].
BERGER, AE ;
DAVIS, JE ;
CRESSWELL, P .
HYBRIDOMA, 1982, 1 (02) :87-90
[3]   CHARACTERIZATION OF A MONOCLONAL ANTI-BETA-2-MICROGLOBULIN ANTIBODY AND ITS USE IN THE GENETIC AND BIOCHEMICAL-ANALYSIS OF MAJOR HISTOCOMPATIBILITY ANTIGENS [J].
BRODSKY, FM ;
BODMER, WF ;
PARHAM, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1979, 9 (07) :536-545
[4]  
CLAASEN HHV, 1992, LAB INVEST, V67, P166
[5]  
DELACRUZ PO, 1990, CANCER-AM CANCER SOC, V65, P112
[6]  
DURIE FH, 1990, INVEST OPHTH VIS SCI, V31, P2106
[7]  
FIDLER IJ, 1985, CANCER RES, V45, P4714
[8]  
GLEW SS, 1992, CANCER RES, V52, P4009
[9]   CYTOTOXIC LYMPHOCYTES-T RECOGNIZE A FRAGMENT OF INFLUENZA-VIRUS MATRIX PROTEIN IN ASSOCIATION WITH HLA-A2 [J].
GOTCH, F ;
ROTHBARD, J ;
HOWLAND, K ;
TOWNSEND, A ;
MCMICHAEL, A .
NATURE, 1987, 326 (6116) :881-881
[10]  
HALLORAN PF, 1992, J IMMUNOL, V148, P3837